3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with methoxy-morpholinyl-doxorubicin in 1 studies
Studies (3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin) | Trials (3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin) | Recent Studies (post-2010) (3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin) | Studies (methoxy-morpholinyl-doxorubicin) | Trials (methoxy-morpholinyl-doxorubicin) | Recent Studies (post-2010) (methoxy-morpholinyl-doxorubicin) |
---|---|---|---|---|---|
38 | 0 | 0 | 50 | 6 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Vries, EG; Meijer, C; Mulder, NH; van der Graaf, WT | 1 |
1 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and methoxy-morpholinyl-doxorubicin
Article | Year |
---|---|
The role of methoxymorpholino anthracycline and cyanomorpholino anthracycline in a sensitive small-cell lung-cancer cell line and its multidrug-resistant but P-glycoprotein-negative and cisplatin-resistant counterparts.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Resistance; Drug Resistance, Multiple; Humans; Lung Neoplasms; Tumor Cells, Cultured | 1995 |